Oncolytic Virus Immunotherapy is a promising cancer treatment that uses a virus's capacity to reproduce and selectively destroy tumour tissue to generate a patient-specific immune response against cancer. Oncolytic Viruses are genetically modified to generate immune-stimulating compounds, as well as making them more selective for cancer cells. Oncolytic virus immunotherapy is frequently coupled with cancer immunotherapies such as therapeutic cancer vaccines and mAb treatment.
Related: Vaccines Conference | Vaccines Congress | Immunization Conference | Vaccines Events | Vaccines Meetings | Immunology Conference | STD-AIDS Conferences | Infectious Diseases Meetings
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
